Detection of erythropoiesis stimulating agent Luspatercept after administration to healthy volunteers for antidoping purposes

Marchand, A; Miller, G; Martin, L; Gobbo, C; Crouch, AK; Eichner, D; Ericsson, M

Marchand, A (通讯作者)，Univ Paris Saclay, Lab Antidopage Francais LADF, 143 Ave Roger Salengro, F-92290 Chatenay Malabry, France.

DRUG TESTING AND ANALYSIS, 2022; 14 (11-12): 1952

Abstract

Luspatercept (Reblozyl (R)) is a newly approved anti-anemic drug prohibited by the World Anti-Doping Agency. It promotes erythropoiesis by limiting ap......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索